Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CVGBM |
Synonyms | |
Therapy Description |
CVGBM is a vaccine comprising lipid nanoparticle-encapsulated mRNA encoding a fusion protein of 8 tumor-associated antigen-derived epitopes, which potentially enhances antitumor immune response (Ann Oncol 35 (2024): S221-S222). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CVGBM | CVGBM is a vaccine comprising lipid nanoparticle-encapsulated mRNA encoding a fusion protein of 8 tumor-associated antigen-derived epitopes, which potentially enhances antitumor immune response (Ann Oncol 35 (2024): S221-S222). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05938387 | Phase I | CVGBM | Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma | Active, not recruiting | NLD | DEU | BEL | 0 |